HMG-CoA Reductase Inhibitor [EPC]

298160 reported adverse events

Drugs of this class: SIMVASTATIN LOVASTATIN EZETIMIBE AND SIMVASTATIN ATORVASTATIN CALCIUM PITAVASTATIN MAGNESIUM ROSUVASTATIN

These side effects are most commonly reported by patients taking drugs of the HMG-CoA Reductase Inhibitor [EPC] class:

#	Side effect	Count
0	FATIGUE	15471
1	NAUSEA	14941
2	DRUG INEFFECTIVE	14616
3	DYSPNOEA	14220
4	DIARRHOEA	13076
5	DIZZINESS	12647
6	ASTHENIA	10752
7	PAIN	10455
8	MYALGIA	10310
9	FALL	10219

See all common reactions for HMG-CoA Reductase Inhibitor [EPC]

Drugs of the HMG-CoA Reductase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	IMMUNE-MEDIATED NECROTISING MYOPATHY	257	0.4597
1	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	181	0.2604
2	MYOPATHY	1533	0.2592
3	HYPERPARATHYROIDISM SECONDARY	421	0.2320
4	RHABDOMYOLYSIS	6593	0.2260
5	NEPHROGENIC ANAEMIA	763	0.2224
6	REBOUND ACID HYPERSECRETION	455	0.1730
7	MYOSITIS	834	0.1540
8	POLYMYOSITIS	191	0.1516
9	SELF ESTEEM DECREASED	186	0.1442

See all enriched reactions for HMG-CoA Reductase Inhibitor [EPC]